The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
CHEK2*1100delC and Susceptibility to Breast Cancer: A Collaborative Analysis Involving 10,860 Breast Cancer Cases and 9,065 Controls from 10 Studies
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Linkage of ATM to Cell Cycle Regulation by the Chk2 Protein Kinase
Matsuoka, S. (1998) · Science · doi:10.1126/science.282.5395.1893 · Cited by 1,322
The CHEK2-Breast Cancer Consortium (2002) · Nature Genetics · doi:10.1038/ng879 · Cited by 1,104
The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis
Falck, J., Mailand, N., Syljuåsen, R. G., Bartek, J., & Lukas, J. (2001) · Nature · doi:10.1038/35071124 · Cited by 1,085
Heterozygous Germ Line hCHK2 Mutations in Li-Fraumeni Syndrome
Bell, D. W., Varley, J. M., Szydlo, T. E., Kang, D. H., Wahrer, D. C. R., Shannon, K. E., Lubratovich, M., Verselis, S. J., Isselbacher, K. J., Fraumeni, J. F., et al. (1999) · Science · doi:10.1126/science.286.5449.2528 · Cited by 904
Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro
Matsuoka, S., Rotman, G., Ogawa, A., Shiloh, Y., Tamai, K., & Elledge, S. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.190030497 · Cited by 829
Chk2/hCds1 functions as a DNA damage checkpoint in G1by stabilizing p53
Chehab, N. H., Malikzay, A., Appel, M., & Halazonetis, T. D. (2000) · Genes & Development · doi:10.1101/gad.14.3.278 · Cited by 805
Day, N., Oakes, S., Luben, R., Khaw, K., Bingham, S., Welch, A., & Wareham, N. (1999) · Nature · doi:10.17863/cam.89388 · Cited by 780
(2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1407 · Cited by 604
hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response
Lee, J.-S., Collins, K. M., Brown, A. L., Lee, C.-H., & Chung, J. H. (2000) · Nature · doi:10.1038/35004614 · Cited by 529
A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes
Antoniou, A. C., Pharoah, P. D. P., McMullan, G., Day, N. E., Stratton, M. R., Peto, J., Ponder, B. J., & Easton, D. F. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600008 · Cited by 495
A CHEK2 Genetic Variant Contributing to a Substantial Fraction of Familial Breast Cancer
Vahteristo, P., Bartkova, J., Eerola, H., Syrjäkoski, K., Ojala, S., Kilpivaara, O., Tamminen, A., Kononen, J., Aittomäki, K., Heikkilä, P., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/341943 · Cited by 467
Replication checkpoint requires phosphorylation of the phosphatase Cdc25 by Cds1 or Chk1
Zeng, Y., Forbes, K. C., Wu, Z., Moreno, S., Piwnica-Worms, H., & Enoch, T. (1998) · Nature · doi:10.1038/26766 · Cited by 344
Polygenic inheritance of breast cancer: Implications for design of association studies
Antoniou, A. C., & Easton, D. F. (2003) · Genetic Epidemiology · doi:10.1002/gepi.10261 · Cited by 232
Syrjakoski, K. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.18.1529 · Cited by 197
Syvänen, A. C., Sajantila, A., & Lukka, M. (1993) · Europe PMC (PubMed Central) · Cited by 195
Vahteristo, P., Tamminen, A., Karvinen, P., Eerola, H., Eklund, C., Aaltonen, L. A., BLOMQVIST, C. P., Aittomäki, K., & Nevanlinna, H. A. (2001) · PubMed · Cited by 180
CHEK2 variant I157T may be associated with increased breast cancer risk
Kilpivaara, O., Vahteristo, P., Falck, J., Syrjäkoski, K., Eerola, H., Easton, D., Bartkova, J., Lukas, J., Heikkilä, P., Aittomäki, K., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20299 · Cited by 163
Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients.
Dörk, T., Bendix, R., Bremer, M., Rades, D., Klöpper, K., Nicke, M., Skawran, B., Hector, A., Yamini, P., Steinmann, D., et al. (2001) · PubMed · Cited by 151
Frequency of CHEK2*1100delC in New York breast cancer cases and controls
Offit, K., Pierce, H., Kirchhoff, T., Kolachana, P., Rapaport, B., Gregersen, P. K., Johnson, S., Yossepowitch, O., Huang, H. J., Satagopan, J. M., et al. (2003) · BMC Medical Genetics · doi:10.1186/1471-2350-4-1 · Cited by 137
Schutte, M. E. M., Seal, S., Barfoot, R., Meijers-Heijboer, H. E. J., Wasielewski, M., Evans, D. G., Eccles, D., Meijers, C., Lohman, F. P., Klijn, J. G. M., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/373965 · Cited by 136
Berns, E. M. J. J., Klijn, J. G. M., van Staveren, I. L., Portengen, H., Noordegraaf, E., & Foekens, J. A. (1992) · European Journal of Cancer · doi:10.1016/s0959-8049(05)80129-7 · Cited by 120
Breastfeeding and breast cancer risk by age 50 among women in Germany
Chang-Claude, J. C., Eby, N. L., Kiechle, M. B., Bastert, G., & Becher, H. (2000) · Cancer Causes & Control · doi:10.1023/a:1008907901087 · Cited by 101
Polymorphic catechol-O-methyltransferase gene and breast cancer risk.
Mitrunen, K., Jourenkova, N., Kataja, V. V., Eskelinen, M. J., Kosma, V., Benhamou, S., Kang, D., Vainio, H., Uusitupa, M. I. J., & Hirvonen, A. (2001) · PubMed · Cited by 86
Osório, A., Rodríguez‐López, R., Dı́ez, O., de la Hoya, M., Martínez, J. I., Vega, A. I., Esteban‐Cardeñosa, E., Alonso, C., Caldés, T., & Benitez, J. J. (2003) · International Journal of Cancer · doi:10.1002/ijc.11414 · Cited by 81
Role of CHEK2*1100delC in unselected series of non‐BRCA1/2 male breast cancers
Neuhausen, S. L., Dunning, A. M., Steele, L., Yakumo, K., Hoffman, M. D., Szabo, C., Tee, L. J., Baines, C., Pharoah, P. D. P., Goldgar, D. E., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.11385 · Cited by 52
Cited by
Genome-wide association study identifies novel breast cancer susceptibility loci
Easton, D. F., Pooley, K. A., Dunning, A. M., Pharoah, P. D. P., Thompson, D., Ballinger, D. G., Struewing, J. P., Morrison, J., Field, H., Luben, R., et al. (2007) · Nature · doi:10.1038/nature05887 · Cited by 2,319
Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk
Easton, D. F., Pharoah, P. D. P., Antoniou, A. C., Tischkowitz, M., Tavtigian, S. V., Nathanson, K. L., Devilee, P., Meindl, A., Couch, F. J., Southey, M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmsr1501341 · Cited by 920
ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles
The Breast Cancer Susceptibility Collaboration (UK), Renwick, A., Thompson, D., Seal, S., Kelly, P., Chagtai, T., Ahmed, M., North, B., Jayatilake, H., Barfoot, R., et al. (2006) · Nature Genetics · doi:10.1038/ng1837 · Cited by 743
Spectrum of Mutations in BRCA1, BRCA2, CHEK2, and TP53 in Families at High Risk of Breast Cancer
Walsh, T., Casadei, S., Coats, K. H., Swisher, E., Stray, S. M., Higgins, J., Roach, K. C., Mandell, J., Lee, M. K., Ciernikova, S., et al. (2006) · JAMA · doi:10.1001/jama.295.12.1379 · Cited by 666
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017
Daly, M. B., Pilarski, R., Berry, M., Buys, S. S., Farmer, M., Friedman, S., Garber, J. E., Kauff, N. D., Khan, S., Klein, C., et al. (2017) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2017.0003 · Cited by 650
Metadata
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2004-06
- Volume
- 74
- Issue
- 6
- Pages
- 1175-1182
- ISSN
- 0002-9297 (ISSN-L)
- OpenAlex
- W2127765486
- Cited by
- 471
- References
- 26
- FWCI
- 20.20
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.